Physicians typically evaluate body composition changes, any side effects, and metabolic markers before continuing or adjusting protocols
ASCII Media Works
By pairing the broad immune-modulating power of LDN with the precise, reparative action of peptides like BPC-157 and Thymosin Alpha-1, this advanced strategy offers a tangible path to break through healing plateaus
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Unlike store-bought products, our GHK-Cu creams and serums are compounded in a regulated pharmacy, ensuring purity, concentration, and effectiveness
Bajaj HS, Welch M, Shah P, et al
